文献速递糖尿病

由糖尿病团队实施院内糖尿病管理及基于连续葡萄糖监测或即时检验血糖的胰岛素滴定算法对2型糖尿病患者的疗效(DIATEC):一项随机对照试验

In-Hospital Diabetes Management by a Diabetes Team and Insulin Titration Algorithms Based on Continuous Glucose Monitoring or Point-of-Care Glucose Testing in Patients With Type 2 Diabetes (DIATEC): A Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2025-01-01

DIATEC为两中心随机对照试验,纳入166例非重症监护病房的2型糖尿病患者,由常规人员按糖尿病团队制定的胰岛素滴定算法管理血糖,算法分别基于即时检验血糖或连续葡萄糖监测(CGM)。结果显示CGM组目标范围内时间(TIR)更高,TIR中位数77.6% vs 62.7%(P<0.001),且CGM组低血糖、血糖变异度、胰岛素用量及院内并发症均较低。

要点

  • CGM组TIR中位数77.6% vs 即时检验组62.7%(P<0.001)
  • CGM组TAR>10.0 mmol/L中位数21.1% vs 36.5%(P=0.001)
  • CGM组延长性低血糖发生率比0.13(95%CI 0.04-0.46;P=0.001)

核心结论

  • 院内CGM使TIR提高15个百分点,主要通过降低TAR实现。
  • CGM还降低了TBR、血糖变异度、延长性低血糖事件、胰岛素用量及院内并发症。

研究设计与样本

  • 两中心随机对照试验,纳入166例非重症监护病房的2型糖尿病患者。
  • 由常规人员实施糖尿病管理,由糖尿病团队依据基于即时检验血糖或CGM的胰岛素滴定算法进行指导。
  • 主要结局为两组间TIR(3.9-10.0 mmol/L)的差异,结局于住院期间评估。

主要发现

  • CGM组TIR中位数(四分位距)为77.6%(24.4%)vs 即时检验组62.7%(31.5%)(P<0.001)。
  • CGM组TAR>10.0 mmol/L中位数(四分位距)为21.1%(24.8%)vs 即时检验组36.5%(30.3%)(P=0.001)。
  • CGM降低TBR<3.9 mmol/L,相对即时检验组的相对差异为0.57(95%CI 0.34-0.97;P=0.042)。
  • 延长性低血糖事件减少(发生率比0.13;95%CI 0.04-0.46;P=0.001);CGM组变异系数均值(标准差)为25.4%(6.3%)vs 即时检验组28.0%(8.2%)(P=0.024)。
  • CGM组总胰岛素剂量均值(标准差)为24.1(13.9)IU/天 vs 即时检验组29.3(13.9)IU/天(P=0.049);并发症复合终点在CGM组更低(发生率比0.76;95%CI 0.59-0.98;P=0.032)。

关键数值与推荐

  • 主要结局TIR(3.9-10.0 mmol/L):CGM组77.6%(24.4%)vs 即时检验组62.7%(31.5%)(P<0.001)。
  • TAR>10.0 mmol/L:CGM组21.1%(24.8%)vs 即时检验组36.5%(30.3%)(P=0.001)。
  • TBR<3.9 mmol/L:CGM相对即时检验组的相对差异0.57(95%CI 0.34-0.97;P=0.042)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Diabetes Team and CGM in Managing Hospitalized Patients With Diabetes (DIATEC) trial investigates the glycemic and clinical effects of inpatient continuous glucose monitoring (CGM)-guided insulin titration by diabetes teams. RESEARCH DESIGN AND METHODS: This two-center trial randomized 166 non-intensive care unit patients with type 2 diabetes. Diabetes management was performed by regular staff, guided by diabetes teams using insulin titration algorithms based on either point-of-care glucose testing or CGM. The primary outcome was the difference in time in range (TIR) (3.9-10.0 mmol/L) between the two arms. Outcomes were assessed during hospitalization. RESULTS: The CGM arm achieved a higher median (interquartile range [IQR]) TIR of 77.6% (24.4%) vs. 62.7% (31.5%) in the POC arm (P < 0.001). Median (IQR) time above range (TAR) >10.0 mmol/L was lower in the CGM arm at 21.1% (24.8%) vs. 36.5% (30.3%) in the POC arm (P = 0.001), and time below range (TBR) <3.9 mmol/L was reduced by CGM, with a relative difference to POC of 0.57 (95% CI 0.34-0.97; P = 0.042). Prolonged hypoglycemic events decreased (incidence rate ratio [IRR] 0.13; 95% CI 0.04-0.46; P = 0.001), and the mean (SD) coefficient of variation was lower in the CGM arm at 25.4% (6.3%) vs. 28.0% (8.2%) in the POC arm (P = 0.024). Mean (SD) total insulin doses were reduced in the CGM arm at 24.1 (13.9) vs. 29.3 (13.9) IU/day in the POC arm (P = 0.049). A composite of complications was lower in the CGM arm (IRR 0.76; 95% CI 0.59-0.98; P = 0.032). CONCLUSIONS: In-hospital CGM increased TIR by 15 percentage points, mainly by reducing TAR. CGM also lowered TBR, glycemic variability, prolonged hypoglycemic events, insulin usage, and in-hospital complications.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Olsen MT, Klarskov CK, Jensen SH, et al. In-Hospital Diabetes Management by a Diabetes Team and Insulin Titration Algorithms Based on Continuous Glucose Monitoring or Point-of-Care Glucose Testing in Patients With Type 2 Diabetes (DIATEC): A Randomized Controlled Trial. Diabetes Care. 2025. PMID: 39887698. doi:10.2337/dc24-2222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。